| Drug-loaded exosomal preparations from different cell types exhibit distinctive loading capability, yield, and antitumor efficacies: a comparative analysis R Kanchanapally, SK Deshmukh, SR Chavva, N Tyagi, SK Srivastava, ... International journal of nanomedicine, 531-541, 2019 | 129 | 2019 |
| Resistin and interleukin-6 exhibit racially-disparate expression in breast cancer patients, display molecular association and promote growth and aggressiveness of tumor cells … SS Deshmukh SK, Srivastava SK, Bhardwaj A, Singh AP, Tyagi N, Marimuthu S ... Oncotarget, 2015 | 123 | 2015 |
| p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling N Tyagi, S Marimuthu, A Bhardwaj, SK Deshmukh, SK Srivastava, ... Cancer letters 370 (2), 260-267, 2016 | 98 | 2016 |
| Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis N Tyagi, SK Srivastava, S Arora, Y Omar, ZM Ijaz, ALG Ahmed, ... Cancer letters 383 (1), 53-61, 2016 | 89 | 2016 |
| Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy SK Deshmukh, SK Srivastava, T Poosarla, DL Dyess, NP Holliday, ... Annals of translational medicine 7 (20), 2019 | 88 | 2019 |
| Exploiting nanotechnology for the development of microRNA-based cancer therapeutics N Tyagi, S Arora, SK Deshmukh, S Singh, S Marimuthu, AP Singh Journal of biomedical nanotechnology 12 (1), 28-42, 2016 | 77 | 2016 |
| Resistin: An inflammatory cytokine with multi-faceted roles in cancer SK Sudan, SK Deshmukh, T Poosarla, NP Holliday, DL Dyess, AP Singh, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1874 (2), 188419, 2020 | 64 | 2020 |
| Gemcitabine treatment promotes immunosuppressive microenvironment in pancreatic tumors by supporting the infiltration, growth, and polarization of macrophages SK Deshmukh, N Tyagi, MA Khan, SK Srivastava, A Al-Ghadhban, ... Scientific reports 8 (1), 12000, 2018 | 64 | 2018 |
| Cancer Immune Checkpoint Inhibitor Therapy and the Gut Microbiota AE Frankel, S Deshmukh, A Reddy, J Lightcap, M Hayes, S McClellan, ... Integrative Cancer Therapies 18, 1534735419846379, 2019 | 63 | 2019 |
| Emerging evidence for the role of differential tumor microenvironment in breast cancer racial disparity: a closer look at the surroundings SK Deshmukh, SK Srivastava, N Tyagi, A Ahmad, AP Singh, ... Carcinogenesis 38 (8), 757-765, 2017 | 62 | 2017 |
| Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor activity compared to conventional gold nanoparticles: Potential synergistic interactions SR Chavva, SK Deshmukh, R Kanchanapally, N Tyagi, JW Coym, ... Nanomaterials 9 (3), 396, 2019 | 55 | 2019 |
| Development and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin Carcinogenesis N Tyagi, A Bhardwaj, SK Srivastava, S Arora, S Marimuthu, SK Deshmukh, ... Scientific reports 5 (1), 13894, 2015 | 55 | 2015 |
| Cellular and molecular progression of prostate cancer: models for basic and preclinical research S Saranyutanon, SK Deshmukh, S Dasgupta, S Pai, S Singh, AP Singh Cancers 12 (9), 2651, 2020 | 51 | 2020 |
| Identification and modeling of a drug target for Clostridium perfringens SM101 G Chhabra, P Sharma, A Anant, S Deshmukh, H Kaushik, K Gopal, ... Bioinformation 4 (7), 278, 2010 | 49 | 2010 |
| Resistin potentiates chemoresistance and stemness of breast cancer cells: Implications for racially disparate therapeutic outcomes SK Deshmukh, SK Srivastava, H Zubair, A Bhardwaj, N Tyagi, ... Cancer letters 396, 21-29, 2017 | 45 | 2017 |
| ETV4 facilitates cell-cycle progression in pancreatic cells through transcriptional regulation of cyclin D1 N Tyagi, SK Deshmukh, SK Srivastava, S Azim, A Ahmad, A Al-Ghadhban, ... Molecular Cancer Research 16 (2), 187-196, 2018 | 43 | 2018 |
| Functional and structural characterization of soluble recombinant epsilon toxin of Clostridium perfringens D, causative agent of enterotoxaemia DD Mathur, S Deshmukh, H Kaushik, LC Garg Applied microbiology and biotechnology 88, 877-884, 2010 | 42 | 2010 |
| Exosomal formulation escalates cellular uptake of honokiol leading to the enhancement of its antitumor efficacy R Kanchanapally, MA Khan, SK Deshmukh, SK Srivastava, M Khushman, ... Acs Omega 5 (36), 23299-23307, 2020 | 36 | 2020 |
| Biological basis of cancer health disparities: resources and challenges for research SK Deshmukh, S Azim, A Ahmad, H Zubair, N Tyagi, SK Srivastava, ... American journal of cancer research 7 (1), 1, 2017 | 36 | 2017 |
| Impact of COVID-19 Pandemic on Ovarian Cancer Management: Adjusting to the New Normal LS Jacome, SK Deshmukh, P Thulasiraman, NP Holliday, S Singh Cancer management and research 13, 359, 2021 | 29 | 2021 |
Sanjeev K SrivastavaAssistant Professor, Mitchell Cancer InstituteVerified email at health.southalabama.edu